Ledger.Open graph →
SEC Form D · filed May 11, 2022

BioAegis Therapeutics, Inc

Offering
$21.8M
Sold
$21.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Morristown, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Mark Dinubile · Morristown, NJExec · DirectorSusan Levinson · Morristown, NJExec · DirectorValerie Ceva · Morristown, NJExec · DirectorTimothy R. Stinson · El Segundo, CAExec · DirectorRamon A. Pino · Fort Lauderdale, FLExec · DirectorCharles B. Krusen · NEW YORK, NYExec · DirectorKelly Lucas · Portland, ORExec · DirectorMichael Wenzlick · Portland, ORExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗